Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04455503
Title Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Evaxion Biotech A/S
Age Groups: senior | adult
Covered Countries AUS

No variant requirements are available.